Butyrate inhibits STING pathway activation in DCs by blocking TBK1 and IRF3 phosphorylation, therefore suppressing type I interferon expression and reducing the tumour‐specific cytotoxic T cell response induced by irradiation. This evidence concerns the gene STING1 and neoplasm.